Similarities between Ozanimod and Sphingosine-1-phosphate
Ozanimod and Sphingosine-1-phosphate have 3 things in common (in Unionpedia): Fingolimod, Multiple sclerosis, Sphingosine-1-phosphate receptor.
Fingolimod
Fingolimod (INN, trade name Gilenya, Novartis) is an immunomodulating drug, mostly used for treating multiple sclerosis (MS).
Fingolimod and Ozanimod · Fingolimod and Sphingosine-1-phosphate ·
Multiple sclerosis
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged.
Multiple sclerosis and Ozanimod · Multiple sclerosis and Sphingosine-1-phosphate ·
Sphingosine-1-phosphate receptor
The sphingosine-1-phosphate receptors are a class of G protein-coupled receptors that are targets of the lipid signalling molecule Sphingosine-1-phosphate (S1P).
Ozanimod and Sphingosine-1-phosphate receptor · Sphingosine-1-phosphate and Sphingosine-1-phosphate receptor ·
The list above answers the following questions
- What Ozanimod and Sphingosine-1-phosphate have in common
- What are the similarities between Ozanimod and Sphingosine-1-phosphate
Ozanimod and Sphingosine-1-phosphate Comparison
Ozanimod has 12 relations, while Sphingosine-1-phosphate has 36. As they have in common 3, the Jaccard index is 6.25% = 3 / (12 + 36).
References
This article shows the relationship between Ozanimod and Sphingosine-1-phosphate. To access each article from which the information was extracted, please visit: